Structural and biochemical characterization of gentisate 1,2-dioxygenase from Escherichia coli O157:H7

被引:50
|
作者
Adams, Melanie A.
Singh, Vinay K.
Keller, Bernd O.
Jia, Zongchao [1 ]
机构
[1] Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada
[2] Queens Univ, Dept Chem, Kingston, ON K7L 3N6, Canada
关键词
D O I
10.1111/j.1365-2958.2006.05334.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Gentisic acid (2,5-dihydroxybenzoic acid) is a key intermediate in aerobic bacterial pathways that are responsible for the metabolism of a large number of aromatic compounds. The critical step of these pathways is the oxygen-dependent reaction catalysed by gentisate 1,2-dioxygenase which opens the aromatic ring of gentisate to form maleylpyruvate. From gentisic acid, the cell derives carbon and energy through the conversion of maleylpyruvate to central metabolites. We have confirmed the annotation of a gentisate 1,2-dioygenase from the pathogenic O157:H7 Escherichia coli strain and present the first structural characterization of this family of enzymes. The identity of the reaction product was revealed using tandem mass spectroscopy. The operon responsible for the degradation of gentisate in this organism exhibits a high degree of conservation with the gentisate-degrading operons of other pathogenic bacteria, including the Shiga toxin-producing E. coli O103:H2, but does not appear to be present in non-pathogenic strains. The acquisition of the gentisate operon may represent a special adaptation to meet carbon source requirements under conditions of environmental stress and may provide a selective advantage for enterohaemorrhagic E. coli relative to their non-pathogenic counterparts.
引用
收藏
页码:1469 / 1484
页数:16
相关论文
共 50 条
  • [1] Escherichia coli O157:H7
    Weir, E
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2000, 163 (02) : 205 - 205
  • [2] Escherichia coli O157:H7
    Hartigan, PJ
    IRISH VETERINARY JOURNAL, 1997, 50 (02) : 91 - +
  • [3] Escherichia coli O157:H7
    Riemann, HP
    Cliver, DO
    VETERINARY CLINICS OF NORTH AMERICA-FOOD ANIMAL PRACTICE, 1998, 14 (01) : 41 - +
  • [4] Escherichia coli O157:H7
    Mead, PS
    Griffin, PM
    LANCET, 1998, 352 (9135): : 1207 - 1212
  • [5] Escherichia coli O157:H7
    Tarr, PI
    Neill, MA
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2001, 30 (03) : 735 - +
  • [6] Escherichia coli O157:H7
    OLoughin, E
    LANCET, 1997, 349 (9064): : 1553 - 1553
  • [7] Immunological characterization of Escherichia coli O157:H7 intimin γ1
    Son, WG
    Graham, TA
    Gannon, VPJ
    CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2002, 9 (01) : 46 - 53
  • [8] Genome structural variation in Escherichia coli O157:H7
    Fitzgerald, Stephen F.
    Lupolova, Nadejda
    Shaaban, Sharif
    Dallman, Timothy J.
    Greig, David
    Allison, Lesley
    Tongue, Sue C.
    Evans, Judith
    Henry, Madeleine K.
    McNeilly, Tom N.
    Bono, James L.
    Gally, David L.
    MICROBIAL GENOMICS, 2021, 7 (11):
  • [9] Characterization of an Escherichia coli O157:H7 marR mutant
    Yaron, S
    White, DG
    Matthews, KR
    INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY, 2003, 85 (03) : 281 - 291
  • [10] Update on Escherichia coli O157:H7
    Lawson J.M.
    Current Gastroenterology Reports, 2004, 6 (4) : 297 - 301